Add-on treatment for refractory hypothyroidism despite adequate replacement with levothyroxine – new patients.
*Amber 0 – following successful 3 month trial (to be conducted in secondary care)*
Please note: all other potential causes of symptoms must be excluded. Patients are eligible for a three month trial initially with the option to continue if there is clinical benefit. Patients with a supressed TSH should be referred for a secondary care opinion before continuing liothyronine in primary care
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist